Revolutionizing Multiple Myeloma Treatment with New Therapy
Professor Julie O'Neal's team found that a long-acting IL-7 helped CAR-iNKT immune cells expand, persist and control multiple myeloma better in mice, with signs of lower inflammatory risk.
Features on peer-reviewed research by scientists at Washington University.
Professor Julie O'Neal's team found that a long-acting IL-7 helped CAR-iNKT immune cells expand, persist and control multiple myeloma better in mice, with signs of lower inflammatory risk.